Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the s... von Minnema, L. A., Giezen, T. J., Egberts, T. C. G., Leufkens, H. G. M., Gardarsdottir, H.

Volltext

Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the s... von Minnema, L A, Giezen, T J, Egberts, T C G, Leufkens, H G M, Gardarsdottir, H

Volltext

Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the s... von Minnema, L. A, Giezen, T. J, Egberts, T. C.G, Leufkens, H. G.M, Gardarsdottir, H

Volltext

Hoe bereikt een nieuw geneesmiddel de patiënt? von Visser, B J, Korevaar, D A, Mokhles, M M, Vermeer-Pragt, W, de Boer, A, Giezen, T J

Volltext

Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory Approval von Giezen, Thijs J., Mantel-Teeuwisse, Aukje K., Straus, Sabine M. J. M., Egberts, Toine C. G., Blackburn, Stella, Persson, Ingemar, Leufkens, Hubert G. M.

Volltext

Risk Minimisation Activities to Minimise Drug-Related Risks: An Overview of Current Practice von Giezen, T. J., Moral, F., Mantel-Teeuwisse, A. K., van Dartel, M., Straus, S. M. J. M., Mülder, S. H., van Zwieten-Boot, B. J.

Volltext

Pharmacovigilance Characteristics and Activities within the First Cohort of EU Risk Management Plans (RMPs): Small Molecules vs. Biologicals von Giezen, T. J., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Egberts, A. C. G., Persson, I., Leufkens, H. G. M.

Volltext

Safety Warnings Issued for Biotechnology Derived Pharmaceuticals Approved Since 1995 von Giezen, T J, Mantel-Teeuwisse, A K, Straus, S MJ, Schellekens, H, C.G.Egberts, A, Leufkens, H GM

Volltext

Safety Assessment and Risk Management of Biologics-Challenges and Opportunities (Biologies SIG) von Giezen, TJ, Keller, B, Sundstrom, A, Kesselheim, AS, Dong, W, Jones, JK, Petri, H

Volltext

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans von Wittfeldt, Ann, MD, Emanuelsson, Håkan, MD, PhD, Brandrup-Wognsen, Gunnar, MD, PhD, van Giezen, J.J.J., PhD, Jonasson, Jenny, PhD, Nylander, Sven, PhD, Gan, Li-Ming, MD, PhD

Volltext

Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI von Georgi, Benjamin, Mielke, Johanna, Chaffin, Mark, Khera, Amit V, Gelis, Lian, Mundl, Hardi, van Giezen, J.J.J, Ellinor, Patrick, Kathiresan, Sekar, Ziegelbauer, Karl, Freitag, Daniel F

Volltext

Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist von Husted, Steen, Van Giezen, J.J.J.

Volltext

Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1 von Armstrong, Duncan, Summers, Claire, Ewart, Lorna, Nylander, Sven, Sidaway, James E., van Giezen, J. J. J.

Volltext

Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP‐induced receptor signaling and platelet aggregation von VAN GIEZEN, J. J. J., NILSSON, L., BERNTSSON, P., WISSING, B.‐M., GIORDANETTO, F., TOMLINSON, W., GREASLEY, P. J.

Volltext

Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection von Brouwer, Philip J.M., Brinkkemper, Mitch, Maisonnasse, Pauline, Dereuddre-Bosquet, Nathalie, Grobben, Marloes, Claireaux, Mathieu, de Gast, Marlon, Marlin, Romain, Chesnais, Virginie, Diry, Ségolène, Allen, Joel D., Watanabe, Yasunori, Giezen, Julia M., Kerster, Gius, Turner, Hannah L., van der Straten, Karlijn, van der Linden, Cynthia A., Aldon, Yoann, Naninck, Thibaut, Bontjer, Ilja, Burger, Judith A., Poniman, Meliawati, Mykytyn, Anna Z., Okba, Nisreen M.A., Schermer, Edith E., van Breemen, Marielle J., Ravichandran, Rashmi, Caniels, Tom G., van Schooten, Jelle, Kahlaoui, Nidhal, Contreras, Vanessa, Lemaître, Julien, Chapon, Catherine, Fang, Raphaël Ho Tsong, Villaudy, Julien, Sliepen, Kwinten, van der Velden, Yme U., Haagmans, Bart L., de Bree, Godelieve J., Ginoux, Eric, Ward, Andrew B., Crispin, Max, King, Neil P., van der Werf, Sylvie, van Gils, Marit J., Le Grand, Roger, Sanders, Rogier W.

Volltext

Biochemistry and Evolution of Anaerobic Energy Metabolism in Eukaryotes von MÜLLER, Miklós, MENTEL, Marek, HELLEMOND, Jaap J. Van, HENZE, Katrin, WOEHLE, Christian, GOULD, Sven B, YU, Re-Young, DER GIEZEN, Mark Van, TIELENS, Aloysius G. M, MARTIN, William F

Volltext

Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model von van Giezen, J. J. J., Sidaway, James, Glaves, Philip, Kirk, Ian, Björkman, Jan-Arne

Volltext

Scaling-up low-carbon urban initiatives: Towards a better understanding von van Doren, Didi, Driessen, Peter PJ, Runhaar, Hens, Giezen, Mendel

Volltext

Biosimilars: what clinicians should know von Weise, Martina, Bielsky, Marie-Christine, De Smet, Karen, Ehmann, Falk, Ekman, Niklas, Giezen, Thijs J., Gravanis, Iordanis, Heim, Hans-Karl, Heinonen, Esa, Ho, Kowid, Moreau, Alexandre, Narayanan, Gopalan, Kruse, Nanna A., Reichmann, Gabriele, Thorpe, Robin, van Aerts, Leon, Vleminckx, Camille, Wadhwa, Meenu, Schneider, Christian K.

Volltext

Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary... von Wang, Kai, Zhou, Xiaorong, Huang, Yanming, Khalil, Mazen, Wiktor, Dominik, van Giezen, J. J. J., Penn, Marc S.

Volltext